The three leading causes of death in Shar-Peis are cancer (15.4%), kidney disorders (13.2%), and behavioral disorders leading to euthanasia (11.0%), based on a study of nearly 2,000 Shar-Peis tracked by the Royal Veterinary College in the UK. Many of these conditions are tied to the same genetic quirk that gives the breed its signature wrinkled skin, making Shar-Peis uniquely vulnerable to a cluster of inflammatory diseases that shorten their lives.
Cancer, Especially Mast Cell Tumors
Cancer is the single biggest killer of Shar-Peis. While many breeds develop cancer in old age, Shar-Peis are unusual because they can develop certain tumors remarkably young. Mast cell tumors, a type of skin cancer, have been documented in Shar-Peis under two years old. In a review of over 800 canine mast cell tumor cases at one diagnostic lab, 18 came from Shar-Peis, and five of those dogs were less than two years old. Four of those five tumors were poorly differentiated, meaning aggressive and fast-growing.
The inguinal area (inner thigh and groin) seems to be a common location for these tumors in young Shar-Peis. Any new lump on a Shar-Pei, especially one that appears suddenly or grows quickly, warrants a vet visit for a needle biopsy. Early detection makes a significant difference in outcomes for mast cell tumors.
Kidney Failure and Amyloidosis
Kidney disorders account for 13.2% of Shar-Pei deaths, and a major reason is a condition called amyloidosis. This happens when abnormal proteins build up in the kidneys and other organs, gradually destroying normal tissue. In affected kidneys, the filtering structures get replaced by waxy deposits, the tubules degenerate, and the organ slowly loses function. In severe cases, these protein deposits also spread to the liver, spleen, lungs, and pancreas, sometimes triggering fatal blood clots.
Amyloidosis in Shar-Peis is not random bad luck. It is directly linked to the breed’s chronic inflammatory condition (more on that below). Each episode of inflammation floods the body with a protein called serum amyloid A, and over time, fragments of that protein accumulate in organs. The damage is irreversible. Once kidney failure sets in, the disease can progress rapidly. One documented case involved a Shar-Pei that died just 10 days after first showing signs of kidney failure, despite aggressive treatment.
Shar-Pei Fever: The Root of Many Problems
A condition called Shar-Pei Autoinflammatory Disease, or SPAID, underlies many of the breed’s fatal health problems. It is a genetic syndrome characterized by recurring episodes of high fever lasting 12 to 48 hours, often accompanied by swollen, painful joints, particularly around the hocks (ankle joints). These episodes can strike as often as every few weeks.
The mechanism starts with the breed’s famous wrinkles. Shar-Peis produce excess hyaluronic acid in their skin, which is what creates those deep folds. But when that hyaluronic acid breaks down, the fragments act like a false alarm to the immune system, triggering the release of inflammatory signals. Those same inflammatory signals tell the liver to produce serum amyloid A, the protein that eventually deposits in organs and causes amyloidosis.
So the chain is: wrinkled skin genetics → excess hyaluronic acid → chronic inflammation → recurring fevers → amyloid protein buildup → organ failure. Not every Shar-Pei with fever episodes develops amyloidosis, but the more frequent and severe the episodes, the higher the risk.
Behavioral Disorders and Euthanasia
The third leading cause of death, at 11.0%, is behavioral disorders. This means euthanasia due to aggression or other behavioral issues that owners or veterinarians deemed unmanageable. Shar-Peis were originally bred as guard dogs, and the breed retains strong territorial and protective instincts. Fearful, nervous, or aggressive temperament is well-documented in the breed. For some owners, severe aggression toward people or other animals becomes a safety issue that ultimately leads to euthanasia.
Genetic Testing for SPAID
Cornell University offers a genetic test that estimates a Shar-Pei’s risk for developing SPAID. The test looks at copies of a specific genetic variant linked to hyaluronic acid overproduction. Results fall into three categories:
- Non-carrier (2 alleles): No expected risk for SPAID.
- Single carrier (6 alleles): Four times the risk of a non-carrier. The dog may develop symptoms during its lifetime.
- Double carrier (10 alleles): Eight times the risk of a non-carrier. The dog is prone to developing SPAID.
This test is most useful for breeders trying to reduce SPAID in their lines, but it also gives owners a clearer picture of what to watch for. A double-carrier Shar-Pei with recurring fevers needs close veterinary monitoring for early signs of kidney damage.
Glaucoma and Quality of Life
While not a top killer, glaucoma is a significant breed-related condition in Shar-Peis that often leads to euthanasia when it becomes unmanageable. Shar-Peis are one of the breeds predisposed to primary glaucoma, where pressure inside the eye builds to painful levels. Values above 50 mmHg cause rapid, permanent blindness. The pain has been compared to a constant severe headache in humans, but dogs often reach much higher pressures than people typically experience.
By the time glaucoma is diagnosed in many cases, the eye is already permanently blind. Treatment can sometimes slow progression in the other eye, but glaucoma in dogs is generally not curable. When medications fail or become unaffordable, removal of the affected eye is sometimes the best option for pain relief. For some owners, bilateral blindness combined with chronic pain contributes to the decision to euthanize.
How Long Shar-Peis Typically Live
Shar-Peis have a shorter lifespan than many similarly sized breeds, generally living 8 to 12 years. The combination of cancer risk, kidney disease, and chronic inflammation compresses their life expectancy compared to other medium-sized dogs. Shar-Peis with frequent fever episodes or early signs of kidney problems tend to fall toward the lower end of that range, while those who avoid or manage SPAID effectively can reach the upper end.
The most impactful thing you can do for a Shar-Pei’s longevity is stay ahead of the breed-specific risks: routine bloodwork to catch kidney changes early, prompt evaluation of any skin lumps, and close attention to fever episodes, including how often they occur and how long they last. Genetic testing before or shortly after acquiring a Shar-Pei helps set realistic expectations and guides monitoring decisions for the dog’s lifetime.